Fatty liver disease is partly genetic. Twin studies estimate that about 52% of the variation in liver fat accumulation comes from inherited factors, with the remaining 48% driven by environment, lifestyle, and measurement variability. So while diet, weight, and alcohol use play major roles, your genes can meaningfully raise or lower your baseline risk, and in some cases explain why certain people develop fatty liver despite being otherwise healthy.
The Gene With the Biggest Impact
The single most influential genetic factor is a variant in a gene called PNPLA3, specifically a mutation known as I148M. This variant interferes with the liver’s ability to break down stored fat. Rather than causing the liver to produce more fat, it slows the process of clearing fat from liver cells, letting triglycerides build up over time.
The effect is dose-dependent. Everyone carries two copies of this gene (one from each parent), and each copy of the risk variant increases liver fat content in a stepwise fashion. People who carry two copies accumulate significantly more liver fat than those with one or none. About 10% of Europeans carry two copies. The variant is considerably more common in Hispanic populations, which helps explain why Hispanic Americans have the highest rates of fatty liver disease in the United States. African Americans, by contrast, carry the variant less frequently and have lower rates of the disease compared to white Americans.
Beyond just fat accumulation, the PNPLA3 risk variant also affects disease progression. In people with alcohol-related cirrhosis, carrying two copies of the variant was associated with a nearly threefold increase in the odds of developing liver cancer compared to those without it. That risk was specific to alcohol-related liver disease and did not appear as strongly in liver disease caused by hepatitis C.
Other Genes That Contribute
PNPLA3 isn’t the only gene involved. Two other well-studied variants also increase the risk of fatty liver and liver damage:
- TM6SF2 (E167K variant): This gene affects how the liver packages and exports fat into the bloodstream. When it doesn’t work properly, more fat stays trapped in the liver. The risk version of this gene is relatively rare in its homozygous form (less than 1% of Europeans carry two copies), but even one copy can raise fatty liver risk.
- MBOAT7: This variant appears to promote lipid accumulation in the liver, though its independent contribution to liver inflammation and scarring is less clear than PNPLA3 or TM6SF2. Studies have found mixed results on whether it drives measurable liver damage on its own.
In children, these same genes matter. Pediatric research has confirmed that PNPLA3 and TM6SF2 variants increase steatosis and fibrosis risk in young people. An additional gene variant called HSD17B13 appears to be protective, meaning some people inherit a genetic advantage that helps shield the liver from damage even when fat does accumulate.
Why Some Lean People Get Fatty Liver
One of the more striking pieces of evidence for a genetic role is the existence of “lean” fatty liver disease, where people with a normal body weight still develop significant liver fat. In a large Korean study, roughly 32% of lean individuals with fatty liver carried risk variants in PNPLA3 or TM6SF2. Having either of these variants nearly doubled the odds of developing fatty liver in the lean group (odds ratio of 1.87). Other genetic variants that matter in overweight populations, like MBOAT7, did not appear to drive the disease in lean individuals.
This is an important point for anyone who has been told they have fatty liver but doesn’t fit the typical profile. Genetics can push liver fat storage above the threshold for disease even without obesity, high alcohol intake, or obvious metabolic problems.
How Genetics Interacts With Lifestyle
That 52% heritability figure doesn’t mean your fate is sealed. It means genetics sets a range of vulnerability, and lifestyle factors determine where you land within that range. Someone with high-risk PNPLA3 variants who maintains a healthy weight and limits sugar and alcohol may never develop clinically significant liver fat. Someone with low genetic risk can still develop fatty liver through sustained weight gain and poor diet.
The interaction also works in the other direction. Weight loss is the most effective treatment for fatty liver regardless of genotype. Studies consistently show that losing 5% to 10% of body weight reduces liver fat substantially, and this benefit holds whether or not you carry risk variants. Genetic predisposition makes the threshold for developing disease lower, but it doesn’t make the disease irreversible or unresponsive to lifestyle changes.
Should You Get Genetic Testing?
No major liver disease society currently recommends routine genetic testing for fatty liver in the general population. The practical reason is straightforward: knowing your PNPLA3 status doesn’t change the treatment plan, which centers on weight management, diet, exercise, and reducing alcohol. Genetic testing for liver conditions is primarily used for rare inherited diseases like genetic cholestatic liver disorders, not for the common metabolic form of fatty liver.
That said, the medical field now formally recognizes the metabolic nature of fatty liver through updated terminology. What was previously called NAFLD (nonalcoholic fatty liver disease) is now called MASLD (metabolic dysfunction-associated steatotic liver disease), a change adopted by major liver associations in 2023. The new name better reflects that the condition is tied to metabolic risk factors like elevated blood sugar, high triglycerides, and excess waist circumference, with or without alcohol use.
If fatty liver runs in your family, the most useful takeaway isn’t to pursue genetic testing but to recognize that your threshold for developing the disease may be lower than average. Earlier attention to metabolic health markers, maintaining a healthy weight, and limiting fructose and alcohol intake can offset a significant portion of inherited risk.